Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.56 |
| ▸ | ESR1 | P03372 | 2/20 | 0.56 |
| ▸ | TAS2R31 | P59538 | 2/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3364494 | 0.92 | MEN1 (0.65) | CYP19A1PTPN1MAPTMEN1KMT2A | |
| SCHEMBL5085606 | 0.90 | CYP19A1 (0.63) | CYP19A1ESR2ESR1TAS2R31PTPN1 | |
| SCHEMBL14829728 | 0.89 | CYP19A1 (0.65) | CYP19A1TAS2R31PTPN1MAPTMEN1 | |
| SCHEMBL6503931 | 0.89 | POLB (0.62) | CYP19A1PTPN1MAPTMEN1KMT2A | |
| SCHEMBL349721 | 0.82 | CYP19A1 (0.62) | CYP19A1ESR2ESR1MAPTMEN1 | |
| SCHEMBL773767 | 0.82 | CYP19A1 (0.66) | CYP19A1ESR2ESR1TAS2R31PTPN1 | |
| SCHEMBL6509053 | 0.81 | CYP1A1 (0.68) | CYP19A1TAS2R31PTPN1MAPTPOLB | |
| SCHEMBL2319144 | 0.81 | CYP19A1 (0.68) | CYP19A1TAS2R31PTPN1MAPTMEN1 | |
| SCHEMBL7200859 | 0.81 | CYP1A1 (0.67) | CYP19A1TAS2R31MAPTTDP1ADORA3 | |
| SCHEMBL17318042 | 0.81 | CYP1A1 (0.67) | CYP19A1TAS2R31MAPTTDP1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1893173-B1 | AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING | UNILEVER PLC (GB) | 2010-10-06 | — | — | EP | claimed |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | CONOPCO, INC. D/B/A UNILEVER | 2008-08-28 | — | — | US | claimed |
| EP-1893173-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS | Unilever Plc (GB) | 2008-03-05 | — | — | EP | claimed |
| WO-2006097191-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS | UNILEVER PLC (GB) | 2006-09-21 | — | — | WO | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
| CN-107753542-B | South American wedelia chinensis antioxidant extract and preparation method and application thereof | 海南师范大学 | 2021-05-07 | — | — | CN | disclosed |
| US-9434908-B2 | Method for extracting an odorous extract by an alternative solvent to conventional solvents | CHARABOT (FR) | 2016-09-06 | — | — | US | disclosed |
| EP-1893173-B1 | AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING | UNILEVER PLC (GB) | 2010-10-06 | — | — | EP | disclosed |
| EP-2082726-A2 | Hair and/or scalp care compositions incorporating flavonoid compounds | Unilever PLC (GB) | 2009-07-29 | — | — | EP | disclosed |
| US-20080287374-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | CONOPCO, INC. D/B/A UNILEVER | 2008-08-28 | — | — | US | disclosed |
| WO-2007115181-A9 | COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF | EASTMAN CHEM CO (US) | 2008-04-03 | — | — | WO | disclosed |
| WO-2006097191-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS | UNILEVER PLC (GB) | 2006-09-21 | — | — | WO | disclosed |
| US-20060135445-A1 | Breast cancer-resistant protein inhibitor | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2006-06-22 | — | — | US | disclosed |
| US-20030166583-A1 | Such as epicatechin coadministered with retinoic acid; bioavailability | HU, OLIVER YOA-PU (TW) | 2003-09-04 | — | — | US | disclosed |
| EP-1286706-A2 | GAMMA IRRADIATION OF PROTEIN-BASED PHARMACEUTICAL PRODUCTS | The American National Red Cross (US) | 2003-03-05 | — | — | EP | disclosed |
| WO-2001087357-A2 | GAMMA IRRADIATION OF PROTEIN-BASED PHARMACEUTICAL PRODUCTS | THE AMERICAN NATIONAL RED CROSS (US) | 2001-11-22 | — | — | WO | disclosed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | disclosed |
| EP-0065123-B1 | HARDLY SOLUBLE SALTS OF AMINOGLYCOSIDE ANTIBIOTICS | MERCK PATENT GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135445-A1 | Breast cancer-resistant protein inhibitor | ABCC1, BCR, BRCA1 | CYP19A1 145/4885ESR2 278/4885ESR1 206/4885 |
| US-20080287374-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | ABCC1, BCR, BRCA1 | CYP19A1 145/4885ESR2 278/4885ESR1 206/4885 |
| US-20030166583-A1 | Such as epicatechin coadministered with retinoic acid; bioavailability | CYP51A1, CYP2E1, CYP7A1 | CYP19A1 29/4885ESR2 397/4885ESR1 319/4885 |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | POLR1C, F3, AKR1C3 | CYP19A1 25/4885ESR2 2056/4885ESR1 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.